Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,110,503
  • Shares Outstanding, K 121,713
  • Annual Sales, $ 563,950 K
  • Annual Income, $ -479,450 K
  • 60-Month Beta 0.87
  • Price/Sales 3.80
  • Price/Cash Flow N/A
  • Price/Book 11.95
Trade GH with:

Options Overview Details

View History
  • Implied Volatility 76.06% ( -0.16%)
  • Historical Volatility 71.70%
  • IV Percentile 86%
  • IV Rank 58.63%
  • IV High 97.32% on 02/22/24
  • IV Low 45.92% on 09/14/23
  • Put/Call Vol Ratio 0.74
  • Today's Volume 974
  • Volume Avg (30-Day) 3,464
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 35,944
  • Open Int (30-Day) 57,241

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.94
  • Number of Estimates 5
  • High Estimate -0.87
  • Low Estimate -1.04
  • Prior Year -1.30
  • Growth Rate Est. (year over year) +27.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.81 +14.48%
on 04/19/24
22.57 -19.81%
on 04/02/24
+0.85 (+4.93%)
since 03/22/24
3-Month
15.81 +14.48%
on 04/19/24
24.02 -24.65%
on 01/29/24
-4.44 (-19.70%)
since 01/24/24
52-Week
15.81 +14.48%
on 04/19/24
41.06 -55.92%
on 08/30/23
-4.97 (-21.54%)
since 04/24/23

Most Recent Stories

More News
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024

Stocks that traded heavily or had substantial price changes on Friday: Sprouts, Block rise; Booking Holdings, Insulet fall

SNBR : 13.57 (-7.05%)
SFM : 65.59 (+0.15%)
ACCO : 4.91 (-1.41%)
GH : 18.10 (+4.38%)
DISCA : 24.43 (+5.90%)
BKNG : 3,517.52 (-0.47%)
PODD : 167.25 (-0.01%)
Guardant Health: Q4 Earnings Snapshot

Guardant Health: Q4 Earnings Snapshot

GH : 18.10 (+4.38%)
Cathie Wood Is Selling This Stock: Should You?

This company hasn't performed well in the past 12 months.

EXAS : 63.24 (-0.46%)
GH : 18.10 (+4.38%)
4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024

Even if Wall Street is wrong about these stocks in the new year, Cathie Wood could still be right about them over the long run.

ARKK : 43.90 (+0.07%)
ARKW : 75.92 (-0.56%)
GH : 18.10 (+4.38%)
ARKG : 23.67 (-1.29%)
BEAM : 22.74 (-3.11%)
DNA : 0.8458 (-2.84%)
NTLA : 21.17 (-1.67%)
Guardant Health: Q3 Earnings Snapshot

Guardant Health: Q3 Earnings Snapshot

GH : 18.10 (+4.38%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1233 (-5.15%)
TELO.VN : 0.180 (+5.88%)
GH : 18.10 (+4.38%)
NTRA : 91.50 (+0.51%)
DGX : 137.55 (+0.62%)
NEO : 14.03 (-0.92%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

/PRNewswire/ -- Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight...

TELO.VN : 0.180 (+5.88%)
TDSGF : 0.1233 (-5.15%)
GH : 18.10 (+4.38%)
NTRA : 91.50 (+0.51%)
DGX : 137.55 (+0.62%)
NEO : 14.03 (-0.92%)
1 Beaten-Down Healthcare Stock to Buy and Hold For 10 Years

This company's fight against a deadly disease could pay off.

GH : 18.10 (+4.38%)
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?

The oncology diagnostic companies are looking for better solutions in early cancer diagnosis.

EXAS : 63.24 (-0.46%)
GH : 18.10 (+4.38%)
Why Guardant Health Stock Jumped 15% This Week

The precision oncology leader benefited from a pair of positive analyst notes this week. Here's what investors need to know.

GH : 18.10 (+4.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 19.13
2nd Resistance Point 18.62
1st Resistance Point 18.36
Last Price 18.10
1st Support Level 17.59
2nd Support Level 17.08
3rd Support Level 16.82

See More

52-Week High 41.06
Fibonacci 61.8% 31.41
Fibonacci 50% 28.44
Fibonacci 38.2% 25.46
Last Price 18.10
52-Week Low 15.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar